在结直肠癌中虫诱导的免疫调节:探索治疗应用
Hongyu Li1,2, Chaojun Shan1, Yunhuan Zhu1
1Key Laboratory of Artificial Organs and Computational Medicine of Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
Frontiers in immunology
|April 29, 2025
概括
虫可以通过免疫调节影响结肠直肠癌的风险和进展. 研究探索虫衍生疗法和基因编辑,用于潜在的结直肠癌治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 微生物学 微生物学
背景情况:
- 结肠直肠癌 (CRC) 是一个重大的全球健康和经济挑战.
- 已经存在的疾病,如结肠炎,肥胖,糖尿病和肠道微生物群的失调可能会影响CRC的发展.
- 免疫系统对虫感染的反应在CRC病变发生过程中起着双重作用.
研究的目的:
- 调查虫和先前存在的疾病对结直肠癌 (CRC) 发展和预后的影响.
- 探索虫衍生物和基因编辑在CRC治疗中的潜力.
- 在CRC的背景下,审查目前对虫与宿主免疫相互作用的理解.
主要方法:
- 关于虫感染,先前存在的疾病及其对结直肠癌的影响的文献综述.
- 对免疫系统反应的分析,包括免疫抑制和免疫细胞激活.
- 探索基因编辑技术,如CRISPR/Cas9,以调节虫对瘤生长的影响.
主要成果:
- 虫诱导的免疫抑制可以通过尽量减少炎症来降低CRC前体病变的风险.
- 相反,虫介导的免疫抑制可能会加速CRC生长和转移,从而对患者的治疗结果产生负面影响.
- 虫衍生物通过激活免疫细胞对抗癌细胞,显示出CRC治疗的潜力.
结论:
- 虫疗法在结直肠癌中具有复杂的双重作用,可能具有保护性和有害性.
- 基因编辑,特别是CRISPR/Cas9,可以调节虫效应以抑制瘤生长.
- 需要进一步的多中心研究来阐明长期治疗效果和综合性CRC治疗的免疫调节途径.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
100
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
100
01:27Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
01:29Drugs for Treatment of Ulcerative Colitis in IBD
102
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
102